
Crizalk 250mg Capsule
Marketer
Pfizer Ltd
Salt Composition
Crizotinib (250mg)
Overview Crizalk 250mg Capsule
Avelox 250mg capsules treat advanced or metastatic non-small cell lung cancer. Consume Avelox 250mg capsules with or without food, consistently at the same time daily for optimal results. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only as directed by your doctor. Common side effects include nausea, vomiting, swelling, and diarrhea. Seek immediate medical attention for serious side effects such as intense abdominal pain, fever, chills, dyspnea, tachycardia, visual disturbances, or altered bowel movements. Liver function monitoring through blood tests may be conducted during treatment. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives. Interactions with other medications are possible; disclose all medications to your healthcare provider. Avoid use during pregnancy or breastfeeding; reliable contraception is crucial for both partners during treatment. A patient support program exists in India, administered by Tata 1mg; consult your doctor or call (1800-102-1618) for details.
Uses of Crizalk 250mg Capsule
Lung cancer (excluding small cell type)
Major Benefits of Crizalk 250mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Crizalk 250mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.
Common Side effects of Crizalk 250mg Capsule:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Visual impairment
- Dizziness
- Taste change
- Fatigue
- Decreased appetite
- Rash
- Decreased white blood cell count (neutrophils)
How to use Crizalk 250mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Crizalk 250mg Capsules. These capsules can be taken with or without food, although consistent timing is recommended.
How Crizalk 250mg Capsule works:
Crizalk 250mg capsules are an anticancer drug that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Crizalk 250mg Capsule is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Crizalk 250mg capsules is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Using Crizalk 250mg capsules while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 250mg Crizalk capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, the administration of Crizalk 250mg capsules requires careful monitoring. Dosage modification of Crizalk 250mg capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Crizalk 250mg capsules; dosage modifications may be necessary. A physician's consultation is recommended. Crizalk 250mg capsules might be contraindicated for patients exhibiting severe hepatic dysfunction.
What if you forget to take Crizalk 250mg Capsule :
Omit any missed dose of Crizalk 250mg Capsule and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Crizalk 250mg Capsule
Label | Value |
---|---|
Chemical Category | Piperidine and Aminopyridine Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Action Class | Kinase inhibitors targeting tyrosine |